ATRA- Atara Biotherapeutics, Inc.

Name: Atara Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atara Biotherapeutics, Inc. (ATRA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Panacea Innovation Ltd	1.32M	$11.05M	-
10%	Adiumentum Capital Fund I LP	377.2K	$3.15M	-
CEO	Nguyen Anhco	143.1K	$1.19M	-
?	Touchon Pascal	78.0K	$650.1K	-
Other	Grant-Huerta Yanina	52.0K	$434.1K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2022	Touchon Pascal82	President And CEO	Sell	14,806	$5.04	$74,548.21	-3.1%	+4.9%	-65.8%
Aug 16, 2022	Dupont Jakob88	EVP, Head Of R&D	Sell	4,124	$5.03	$20,760.22	-2.5%	+4.9%	-65.8%
Aug 16, 2022	Koppikar Utpal76	Chief Financial Officer	Sell	5,940	$5.04	$29,907.90	-2.9%	+4.9%	-65.8%
Jun 27, 2022	Touchon Pascal82	President And CEO	Sell	14,220	$7.20	$102,384.00	-2.9%	-51.8%	-75.7%
Jun 8, 2022	Koppikar Utpal76	Chief Financial Officer	Sell	5,853	$5.63	$32,952.39	-2.8%	-28.1%	-68.0%
May 17, 2022	Murugan Amar80	SVP, GC &Secretary	Sell	3,223	$5.32	$17,134.37	-1.2%	-4.5%	-63.1%
May 17, 2022	Koppikar Utpal76	Chief Financial Officer	Sell	5,582	$5.32	$29,674.88	-1.3%	-4.5%	-63.1%
May 17, 2022	Dupont Jakob88	EVP, Head Of R&D	Sell	3,873	$5.32	$20,596.61	-2.3%	-4.5%	-63.1%
May 17, 2022	Touchon Pascal82	President And CEO	Sell	13,913	$5.32	$73,961.51	-2.8%	-4.5%	-63.1%
Mar 1, 2022	Koppikar Utpal76	Chief Financial Officer	Sell	3,763	$9.86	$37,089.62	-0.9%	-49.1%	-61.7%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC